Polarean Imaging plc (PLLWF)
- Previous Close
0.0000 - Open
0.0200 - Bid 0.0210 x --
- Ask --
- Day's Range
0.0200 - 0.0200 - 52 Week Range
0.0100 - 0.0520 - Volume
50,000 - Avg. Volume
675 - Market Cap (intraday)
16.443M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
polarean.comRecent News: PLLWF
View MorePerformance Overview: PLLWF
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLLWF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLLWF
View MoreValuation Measures
Market Cap
14.78M
Enterprise Value
3.17M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.30
Price/Book (mrq)
1.09
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--